TrialA Study of AL102 in Patients With Progressing Desmoid Tumors
Trial details
- Registry ID
- NCT04871282
- Phase
- Phase 2, Phase 3
Drug research
AL102
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as varegacestat
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of AL102 in Patients With Progressing Desmoid TumorsNCT04871282 | IMNM | Phase 2, Phase 3 | Active not recruiting | 2025-12-03Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |